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between HIV/AIDS patients (37/52) and BD (113/150).
Concurrent latent/persistent HHV-6 and HHV-7 infections
was found much more often in CFS patients (25/49) and
patients with HIV infection (32/52) in comparison with
BD (49/150). The freguency of active HHV-7 infections
signiﬁcally higher in HIV/AIDS patients (19/37) in comparison
with BD (12/113). Active concurrent herpesvirus infections
were observed in HIV/AIDS (10/32) and (9/25) CFS patients
only.
Conclusion: Active infection with both HHV-6 and HHV-7
more frequent in patients with CFS and HIV/AIDS than in
BD.
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OL-046 Efﬁcacy of interferon plus ribavirin therapy in
chronic hepatitis C Patients: A Nepali study
K.C. Sudhamshu*. Liver Unit, National Academy of Medical
Sciences, Bir Hospital, Kathmandu, Nepal
Backgrounda and Aim: Before the availability of pegylated
interferon, interferon therapy in chronic hepatitis C patients
was almost a failure in Nepal. This study was carried out to
determine the efﬁcacy of peg-interferon (2a) plus ribavirin
in Nepali patients.
Method: Thirty-seven consecutive patients with anti HCV
test report were enrolled in the study from April 2004
to December 2007. Chronic hepatitis was conﬁrmed by
raised aminotransferase and presence of HCV RNA by PCR.
Peg-interferon was given in a dose of 180 mcg per week
subcutaneously and dose was adjusted whenever required.
Ribavirin was given in a dose of 800 1000mg/day. Viral load
was repeated after 4th dose, 12th dose, last dose, after 3
month and 6 month of treatment.
Results: Thirty-ﬁve patients showed detectable HCV RNA
by PCR. 30 patients were treated and 29 followed up as 1
patient was lost in follow up. The genotype was 1 in 5, 2
in 9, 3 in 15 patients. 14 patients were super responder (9
type 3 and 5 type 2), while 12 patients were free of virus
after 12 weeks of treatment. End treatment response (ETR)
was 100% and sustained viral response (SVR) was achieved
in 96.5%. Neutropenia was the commonest side effect of
interferon while side effects of ribavirin were not seen.
Conclusions: Peg-interferon and ribavirin was well tolerated
in Nepali patient. ETR was 100% and SVR was 96.5% in small
cohort of patient. 12 weeks therapy may be considered in
type 2 and 3 due to cost factor.
OL-047 Evaluation of anti-HCV samples deemed positive
by chemiluminescent assay using recombinant
immunoblot assay
Y.L. Dou*, X.Z. Guo, A.P. Ni, W.J. Yan. Department of
Clinical Labs Union Medical College Hospital Chinese
Academy of Medical Science, Beijing, 100730, China
Objective: To conduct conﬁrmative study of anti-
HCV positive samples deemed positive by the second-
tier and third-tier hospitals in China using two fully
automatic chemiluminescent assay instrument, i2000
(ARCHITECT iSystem) and ECI (the Ortho-Clinical
Diagnostics Vitros ECI Anti-HCV with the use of the
CHIRON RIBA (Recombinant Immunoblot Assay) HCV3.0strip
immunoblot assay (SIA) method. For the purpose to evaluate
the rationality positive boundary value of the s/co for
screening the HCV-positive samples. A boundary value of
s/co has been speciﬁed such that any sample screened
positive with s/co ratio greater than the boundary value
would be at least better than 95% truly positive and
therefore need not to undergo conﬁrmatory RIBA test. more
accurate clinical diagnosis of HCV case.
Methods: First, screen out Anti-HCV samples that signal-to-
cutoff (s/co) is 1 20 in the ARCHITECT-i2000 or the Vitros ECI
is 1 35. Then, Chiron RIBA HCV3.0 SIA test was performed
to conﬁrm the Anti-HCV serological results from the two
companies’ instruments. Followed by checking the HCV RNA
with real time PCR. Lastly, perform statistical ROC curve
processing to determine the boundary value of S/CO for
screening anti-HCVpositive samples.
Results: Among the 203 samples, 33 (16%) were conﬁrmed
RIBA negative and HCV RNA negative; 93samples (46%) were
found RIBA positive but in which only 30 (32.3%) samples
were also HCV RNA positive, 77 samples (38%) were found
RIBA indeterminate and HCV RNA negative. In terms of
sensitivity, the ARCHITECT i2000 analyzer is 99% and the
Vitros ECI was found to be 100%. In terms of speciﬁcity, the
ARCHITECT i2000 was found to be 61%; The Vitros ECI to
be 52%. In terms of anti-HCV position predictive value, the
ARCHITECT i2000 analyzer was 100% on s/co > 6.06 while the
Vitros ECI analyzer was 100% on s/co > 12.35.
Conclusion: The criteria of Anti-HCV s/co > 1 is reasonable
for screening test using fully automatic Chemiluminescent
assay with assurance of sensitivity greater than 97%.
The anti-HCV positive samples can be fairly conﬁrmed if
s/co > 6.05 is measured by the architect I2000 analyzer and
s/co > 12.35 is measured by the Vitros ECI analyzer. When
s/co is measured 1.0 6.5 by the ARCHITECT i2000 analyzer
and 1.0 12.5 by the Vitros ECI analyzer, it is suggested to
perform conﬁrmatory RIBA HCV3.0 SIA test if affordable or
perform HCV RNA test, but it may be more realistic to have
periodic re-examination of anti-HCV samples.
OL-048 Identiﬁcation of Helicobacter hepaticus and
Helicobacter species in liver samples from
Egyptian patients with hepatitis C cirrhosis with
or without hepatocellular carcinoma
M. Grauer1, R. Ludwig1, G. Badra2 *, A. Ljungh3, I. Waked2,
M. Saleh2, A. El Refaey2, I. Marwan2, D. Schuppan4,
E.G. Hahn1, P.C. Konturek1. 1Dept. of Medicine I,
University Hospital, Friedrich-Alexander University
Erlangen-Nuremberg; D-91054 Erlangen, Germany,
2National Liver Institute, Menouﬁya University, Shebeen el
Koom, Egypt, 3Dept. of Medical Microbiology, Dermatology
and Infection, University of Lund, Sweden, 4Division of
Gastroenterology, Beth Israel Deaconess Medical Center,
Harvard Medical School, Boston, MA 02215, USA
Background and Aims: Helicobacter pylori is a recognized
type I carcinogen. Although there is a mouse model,
where liver ﬁbrosis and hepatocellular carcinoma (HCC)
are induced by infection with H. hepaticus, pathogenicity of
enterohepatic Helicobacter (EHS) in man is still undeﬁned.
Methods: 105 liver biopsies, 60 from patients with chronic
hepatitis C infection and 45 from patients with HCV
infection and HCC were collected in Egypt. Helicobacter
DNA was detected by genus-speciﬁc 16S rDNA PCR and DNA
sequencing (BLAST). Sera were tested for antibodies of
different Helicobacter species (EIA, Immunoblot).
Results: 16S rDNA were found positive in 52.4%. In chronic
HCV without HCC 51.7% while in chronic HCV with HCC
53.3% were positive respectively. H. hepaticus DNA was
detected in chronic HCV without HCC in 35% and in 13.3%
in chronic HCV with HCC. Antibody detection was positive
in patients with hepatitis C without HCC for H. pylori in
67% and H. hepaticus in 22% while antibody detection was
positive for H. pylori in 64% and H. hepaticus in 16% in
patients with HCC.
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Conclusions: PCR and DNA sequencing detected the
presence of H. hepaticus more often in liver biopsies with
HCV infection without than with concomitant HCC.
OL-049 Screening of proteins binding to HCV NS3
protein from human pancreas cDNA library by
yeast two-hybrid
C.C. Hu, J.Q. Zhang*, X.C. Wang, G.L. Li, Q. Wang,
J. Cheng. Institute of Infectious Diseases, Beijing Ditan
Hospital, Beijing 100011, China
Objective: To screen proteins of human pancreas cDNA
library interacting with HCV NS3 protein.
Methods: The library was amplifed, puriﬁed and evaluated,
and then the puried library plasmids were transformed
into yeast strain Y187. The reconstructed plasmid pGBKT7-
NS3 was transformed into yeast strain AH109 and
screened on the nutrient deﬁciency medium SD/-Trp.
The transformed AH109 mated with Y187 containing the
library plasmid. The diploid yeast cells were plated on
nutrient deﬁciency medium SD/-Trp/-Leu/-His/-Ade and
SD/-Trp/-Leu/-His/-Ade containing X-a-gal for selecting.
The plasmids in diploid yeast cells were extracted and
electrotransformed into E. coli DH5a. The plasmids in DH5a
were extracted, sequenced and analyzed by bioinformatic
methods.
Results: Eight proteins interacting with HCV NS3 were
found.
Conclusions: These results show that HCV NS3 protein may
be related with metabolism of glucose and lipid.
Supported by the National Natural Science Foundation of
China, No. 30600524.
OL-050 Extended Programme of Immunization (E.P.I) in
Pakistan; shadow shift from polio to hepatitis,
the threatening upcoming challenge
T. Hussain1 *, R. Ara2. 1Department of Cardiology, Union
Hospital, International Students/Doctors Building, Tongji
Medical College, Wuhan, China, 2Department of Law,
Islamabad, Pakistan
Background and Aims: In past, EPI-Pakistan focused primar-
ily on diseases like Polio/Measles/Mumps/Tuberculosis, but
as ﬁgures switched from 238 Polio, 0.3 Million Hepatitis-B
and nearly 0.45 Million Hepatitis-C registered cases in
1997 to 30 Polio, 5.3 Million Hepatitis-B and 4.9 Million
Hepatitis-C cases in 2007, government changed the policy,
making a stress over Hepatitis-B control.
HBV/HCV is well known to cause hepatitis/related
complications throughout the world, proving a threatening
challenge to developing countries. Study aim was to
estimate seropositivity levels of HBV/HCV among apparently
healthy young population.
Methods: Study was conducted at Holy-Family Hospital
Rawalpindi, Pakistan. Over a period of 6months, 500cases
aged between 20 40Years including 50Doctors and 450
routine blood-donors were screened after written-informed
consent. They had neither any sign nor symptom of
acute/chronic liver-disease. Samples were screened for
HBsAg and Anti-HCV-antibodies. Cases found positive for
HCV-Ab were interviewed for possible risk factors.
Results: Overall 52% were male, 6.4% positive for HBsAg,
male-female ratio 38:27, mean-age 24±4 years, 4.7%
positive for Anti-HCV-antibodies, mean-age 25±3 years and
0.33% positive for both. Overall infection-rate was 3.3%.
Prevalence-rate of Anti-HCV-antibodies (4.7%) was less than
HBsAg positivity (6.4%). There was no signiﬁcant overlap
(0.5%) between seropositivity of Anti-HCV with HBsAg,
reﬂecting different epidemiological-factors. Cases with
Anti-HCV antibodies were further evaluated; 56% were with
raised ALT, 79% had risk factors including blood-group testing
(71%), parenteral-medications/needle/prick-injuries (71%),
dental-procedures (19%), previous-surgery/tattoo-markings
(15%), unsafe-sex (19%) and multiple blood-transfusions
(2%). 7% gave no history of possible exposure. 16 doctors
positive for virus (14Hep-B and 2Hep-C), all gave history of
needle-prick injuries.
Conclusion: Hepatitis B-Vaccine inclusion in EPI-Pakistan
will decline its prevalence but HCV mostly spread via
health-care facilities, so behavior-modiﬁcation is superior
to clinical therapy as minimizing all types of needle-pricks
is advised till proper aseptic practice.
Acknowledgement: Dr. Abbas Hayat, Dr. Sara Tajammul, Dr.
Aamra Sartaj and Ali Mumtaz.
OL-051 Detect the gene expression inﬂuence after the
interaction between HCV NS4A and CAML with
microarray assay
Y.Q. Cheng*, Y. Liu, L. Wang, J. Cheng, D.P. Xu, Y.W. Zhong,
J.Z. Dai, X.D. Li. The 302 Hospital of PLA, Beijing 100039,
China
Aim: To understand gene expression inﬂuence after the
interaction between HCV NS4A and CAML.
Methods: The expressive vector of pCMV/Myc-NS4A
and pcDNA3.1/HisA-CAML were constructed by routine
molecular biological methods. The 293 cells were
transfected by pCMV/Myc-NS4A and pcDNA3.1/HisA-CAML,
respectively using lipofectamine. The total RNAwas isolated
and reverse transcribed. The cDNAs were subjected for
microarray screening.
Results: The expressive vector has been constructed
and conﬁrmed by restriction enzyme digestion and DNA
sequencing analysis. The expression of CAML protein has
been conﬁrmed by Western blot with single chain variable
region (scFv) antibody. High quality mRNA and cDNA had
been prepared and successful microarray screening had
been conducted. From the scanning results, it was found
7 genes related to cell apoptosis, among them, 4 were
up-regulated and 3 were down-regulated.
Conclusion: The expression of NS4A protein affected the
expression spectrum of 293-CAMLcells, especially some
genes related to cell apoptosis pass way. HCV NS4A maybe
will have some negative effect on the progress of cell
apoptosis, and then lead to the chronic HCV infection.
OL-052 Successful preventive programs in reducing HCV
prevalence and increase blood safety in Abadan
blood donors during 2005 2008
A. Jalali Far Mohammad1, N. Navidpor1, M. Paridar1,
A.H. Ghasemzadeh1, M. Samadi1, J. Torabizadeh maatoghi1,
N. Saki2, S. Negravi3. 1Ahwaz blood transfusion service,
Pasdaran Boulevard, Ahwaz Khouzestan province, Iran;
Iranian Blood Transfusion Organization Research Center,
Iran, 2Hematology Dep. Tarbiat Modares University, Tehran,
Iran, 3Padideh English institute, Iran
Estimated 3% of the world population is infected with
hepatitis C virus and 20% of patients progress to liver
cirrhosis with an increased risk for the development of
hepatocellular carcinoma. In the United States alone, nearly
four million persons are infected and 30,000 acute new
infections are estimated to occur annually. Because the
role of transfusion in HCV transmission and the high number
of blood transfusion dependent patients in Abadan, study of
HCV prevalence in 3 years helps us to evaluating the efﬁcacy
of preventive program in increase the blood safety.
In this descriptive cross sectional survey we studied all
blood donors that referred to Abadan blood center during
